Altium Capital Management LLC / ADMA
Altium Capital Management LLC’s Adma Biologics Inc Position
Does Altium Capital Management LLC own Adma Biologics Inc (ADMA)? Not currently — the last reported position was 1.40M shares worth $24M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$24M
Q4 2024
Shares
1.40M
% of Portfolio
+6.79%
Quarters Held
13
position exited
Position History ADMA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 1.40M | $24M | +6.79% |
| Q3 2024 | 1.36M | $27M | +8.00% |
| Q2 2024 | 1.51M | $17M | +6.89% |
| Q1 2024 | 1.54M | $10M | +4.02% |
| Q4 2023 | 1.09M | $5M | +3.36% |
| Q3 2023 | 2.72M | $10M | +5.08% |
| Q2 2023 | 2.38M | $9M | +6.65% |
| Q1 2023 | 2.87M | $9M | +5.27% |
| Q4 2022 | 2.87M | $11M | +5.66% |
| Q3 2022 | 2.88M | $7M | +2.57% |
| Q2 2022 | 4.00M | $8M | +3.17% |
| Q1 2022 | 3.30M | $6M | +2.02% |
| Q4 2021 | 3.30M | $5M | +1.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ADMA.